Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Operating Margin (2016 - 2026)

Aytu Biopharma has reported Operating Margin over the past 13 years, most recently at 12.99% for Q4 2025.

  • Quarterly Operating Margin fell 254.0% to 12.99% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.85% through Dec 2025, down 327.0% year-over-year, with the annual reading at 11.79% for FY2025, 935.0% down from the prior year.
  • Operating Margin was 12.99% for Q4 2025 at Aytu Biopharma, down from 10.83% in the prior quarter.
  • Over five years, Operating Margin peaked at 44.43% in Q2 2023 and troughed at 220.76% in Q1 2022.
  • The 5-year median for Operating Margin is 12.99% (2025), against an average of 35.7%.
  • Year-over-year, Operating Margin crashed -18031bps in 2021 and then soared 18311bps in 2023.
  • A 5-year view of Operating Margin shows it stood at 48.84% in 2021, then skyrocketed by 46bps to 26.13% in 2022, then skyrocketed by 164bps to 16.78% in 2023, then crashed by -162bps to 10.45% in 2024, then fell by -24bps to 12.99% in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Operating Margin are 12.99% (Q4 2025), 10.83% (Q3 2025), and 50.37% (Q2 2025).